期刊文献+

三维适形放射治疗25例肝癌临床分析

Clinical Analysis of Three_Dimensional Conformal Radiation Therapy of 25 Cases Liver Carcinoma
下载PDF
导出
摘要 目的评价肝癌用三维适形放射治疗的疗效。方法对25例肝癌患者采用三维适形放射治疗,原发性肝癌16例,转移性肝癌9例;7例曾行1。2次介入治疗。肿瘤体积2.91~685.9cm^3,平均125.25cm^3,中位体积14.05cm^3。设3—5个共面等中心照射野,80%。90%的等剂量线包绕PTV,靶区包括肿瘤边缘外0.5~1.5cm,用6MV—X线照射,总量为DT43.2—54Gy,2.25—3.6Gy/F,每周5次,放疗结束后1-2个月复查CT。结果本组25例,CR5例(20%),PR14例(56%),SD5例(20%),PD1例(4%),有效率CR+PR为76%。结论三维适形放射治疗适用于肝癌的治疗,不良反应小,效果明显,但制订治疗计划时应充分考虑放射性肝病的发生概率。 Objective To evaluate the effects of three-dlmensional conformal radiation therapy on liver carcinoma. Methods Between August 2003 to January 2006,25 cases with liver carcinoma were treated with three-dimensional conformal. Ofall the cases 17 were men, 8 were women, mean age 53, range from 14 to 70. Of the 25 patients 16 were primary hepatic cancer, 9 were metastatic hepatic cancer. Among them 7 patients were treated with 1 -2 times of transcatheter arterial chemoembolization (TACE). Irradiation ridded had 3- 5,80% -90% isodose line included PTV. The total radiation dose of 43.2 - 54 Gy,2.25 - 3.6 Gy/F,5F/W. For 3DCRT, radiation was given by 6MV-X. Results In all the patients, the overall response rate was 76%. 5(20% ) were complete response (CR), 14(56% ) partial response (PR), stable response (SD), progressive response (PD). Conclusions 3DCRT was feasible in the treatment of liver carcinoma, with good immediate tumor response, and milder toxicity.
作者 孙伟
出处 《肿瘤基础与临床》 2006年第6期497-498,共2页 journal of basic and clinical oncology
关键词 肝脏肿瘤 放射疗法 适形 liver neoplasms radiotherapy, conformal
  • 相关文献

参考文献6

二级参考文献53

  • 1吴孟超,陈汉,姚晓平,杨甲酶,杨广顺,沈锋.原发性肝癌的外科治疗[J].中华外科杂志,1996,34(12):707-710. 被引量:121
  • 2[1]Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics,2002. CA Cancer J Clin. 2005, 55 (2):74 被引量:1
  • 3[2]Parkin FDM. Global cancer statistics in the year 2000. Lancet Oncol. 2001, 2 (9):533 被引量:1
  • 4[5]Carr BI. Hepatocellular carcinoma: Current management and future trends. Gastroenterology. 2004, 127 (5 Suppl 1):S218 被引量:1
  • 5[6]Song TJ, Ip EW, Fong Y. Hepatocellular carcinoma: Current surgical management. Gastroenterology. 2004, 127 (5 Suppl 1): S248 被引量:1
  • 6[7]Bober J, Samek P. Surgery of the tumours of the liver. Bratisl LekListy, 2002, 103:403 被引量:1
  • 7[11]Liaw YF. Prevention and surveillance of hepatitis B virus - related hepatocellular carcinoma. Semin Liver Dis, 2005, 25Suppl 1:40 被引量:1
  • 8[12]Rasi G, Pierimarchi P, Sinibaldi Vallebona P, et al. Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma. Int Immunopharmacol,2003, 3 (8):1169 被引量:1
  • 9[14]Van Vlierberghe H, Borbath I, Delwaide J, et al. BASLguidelines for the surveillance, diagnosis and treatment of hepatocellular carcinoma. Acta Gastroenterol Belg, 2004, 67 (1):14 被引量:1
  • 10[15]Llovet JM. Evidence - based medicine in the treatment of hepatocellular carcinoma. J Gastroenterol Hepatol. 2002, Suppl 3:S428 被引量:1

共引文献164

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部